Bionano Genomics Inc (NASDAQ:BNGO)
| 1.10 Delayed Data As of Mar 24 |  +0.01 / +0.92%Today’s Change | 1.06 Today|||52-Week Range 4.35 | -24.66% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Assets | Cash | 5.2M | 1.0M | 16.5M | -- | |
| Short Term Investment Cash | 584.9K | -4.2M | 15.5M | -- | ||
| Cash & Short Term Investments | 5.2M | 1.0M | 16.5M | -- | ||
| Receivables | Receivables | 1.8M | 3.4M | 4.5M | -- | |
| Inventories | Inventories | 2.8M | 2.2M | 1.1M | -- | |
| Current Assets | Prepaid Expenses | -- | -- | 460.7K | -- | |
| Other Current Assets | 802.5K | 579.2K | 384.1K | -- | ||
| Current Assets | 10.7M | 7.1M | 23.0M | -- | ||
| Total Assets | Property, Plant and Equipment - Gross | 6.5M | 6.9M | 6.9M | -- | |
| Depreciation | -2.4M | -3.9M | -5.2M | -- | ||
| Other Assets | 0.00 | 0.00 | 0.00 | -- | -- | |
| Total Assets | 14.8M | 10.1M | 24.8M | -- | ||
| Liabilities | Accounts Payable | 792.3K | 2.3M | 1.4M | -- | |
| Short Term Debt | 587.1K | 6.7M | 0.00 | -- | ||
| Accrued Expenses | 2.2M | 2.6M | 2.1M | -- | ||
| Other Current Liabilities | 7.3M | 6.7M | 2.4M | -- | ||
| Other Liabilities | 9.4M | 16.7M | 4.5M | -- | ||
| Total Liabilities | Long Term Debt | 6.0M | 0.00 | 9.0M | -- | |
| Other Liabilities | 975.4K | 567.0K | 808.4K | -- | ||
| Total Liabilities | 16.6M | 17.4M | 14.7M | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock | 25.4M | 43.0M | 0.00 | -- | ||
| Common Equity | -27.3M | -50.2M | 10.1M | -- | ||
| Total Shareholder Equity | -1.8M | -7.2M | 10.1M | -- | ||
| Share Information | Common Shares Outstanding | 10.0M | 10.0M | 10.1M | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
